Take action now! Visit HomeopathyChoice.org
As of December 20, 2017, the FDA is currently introducing new draft guidance for “Drug Products Labeled as Homeopathic” that targets the restriction of certain homeopathic remedies through illegal regulations. This document, if ratified, threatens access to homeopathic products in the United States and could set dangerous precedent, limiting the rights of individuals to choose their own appropriate healthcare. Our time is limited, and we need your help. We have until March 20, 2018 to submit comments to the FDA.
Visit HomeopathyChoice.org to take action now!